untitled design

Commission – Moderna agreement on new timetables for the delivery of vaccines against the coronavirus

The European Commission and Moderna have reached a new agreement to better address member states’ needs for Covid-19 vaccines for the late summer and winter season. In this way, member states will have access to vaccines, including those adapted to the variants, once they are approved, at the time they are needed for their vaccination campaigns.

The agreement adjusts the originally agreed delivery schedules. Doses originally scheduled for delivery in the summer will now be delivered in September and during the fall and winter of 2022, when Member States will likely need additional vaccine stocks for their national campaigns and to meet the of their international commitments for solidarity.

The agreement also ensures that if one or more adapted vaccines are authorised, Member States can choose to receive those adapted vaccines under the current convention.

In this context, at the request of certain Member States, the agreement also secures from Moderna an additional 15 million doses of a candidate booster vaccine against the Omicron variant, subject to obtaining marketing authorization within timetables that would allow the use of these doses for vaccination campaigns their.

By the end of July 2022, the EU had exported over 2.4 billion doses of vaccines to 168 countries. Member States have made available over 478 million doses, of which around 406 million have already been delivered to recipient countries (around 82% of these through the COVAX mechanism). At the same time, Member States must continue to ensure that they have the strategic stocks of vaccines needed to address the potential epidemiological evolution of the coronavirus, given the uncertainties about its future evolution and impact.

Source: Capital

You may also like

Nasdaq 100 could fall to 16,800
Markets
Joshua

Nasdaq 100 could fall to 16,800

Change in the Nasdaq 100 Selling on the Nasdaq 100 from April 12 to 19, which sent the index down

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular